Profile data is unavailable for this security.
About the company
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
- Revenue in USD (TTM)441.03m
- Net income in USD-80.10m
- Incorporated2007
- Employees2.40k
- LocationAccolade Inc660 W. Germantown Pike Suite 500PLYMOUTH MEETING 19462United StatesUSA
- Phone+1 (610) 834-2989
- Fax+1 (302) 636-5454
- Websitehttps://www.accolade.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nutex Health Inc | 275.93m | -37.89m | 151.75m | 800.00 | -- | 2.22 | -- | 0.55 | -8.45 | -8.45 | 58.91 | 12.58 | 0.6427 | 85.57 | 4.71 | 344,910.60 | -6.93 | -69.35 | -8.57 | -84.85 | 19.21 | 10.97 | -10.79 | -102.85 | 1.55 | 0.9375 | 0.7683 | -- | 12.93 | 428.22 | 89.22 | -- | -- | -- |
| Longduoduo Co Ltd | 7.39m | 1.26m | 158.73m | 49.00 | 126.43 | 225.94 | 108.32 | 21.48 | 0.0418 | 0.0418 | 0.2463 | 0.0234 | 4.17 | 422.80 | 61.99 | 150,812.90 | 76.89 | -- | 1,467.79 | -- | 97.65 | -- | 18.45 | -- | 1.31 | -- | 0.00 | -- | 93.52 | -- | 3,311.69 | -- | -- | -- |
| Joint Corp | 120.07m | -14.41m | 188.66m | 444.00 | -- | 8.12 | -- | 1.57 | -0.9743 | -0.9743 | 8.07 | 1.55 | 1.32 | -- | 33.77 | 270,430.40 | -15.86 | 4.32 | -23.50 | 6.05 | 90.82 | 90.28 | -12.00 | 3.68 | -- | 1,156.17 | 0.0022 | -- | 16.24 | 26.27 | -1,656.09 | -- | 35.09 | -- |
| Biodesix Inc | 65.56m | -43.82m | 205.11m | 217.00 | -- | 7.36 | -- | 3.13 | -0.3941 | -0.3941 | 0.5663 | 0.1915 | 0.6918 | -- | 9.49 | 302,129.00 | -46.24 | -55.60 | -60.89 | -80.94 | 77.72 | 59.53 | -66.84 | -105.15 | -- | -3.91 | 0.5647 | -- | 28.46 | 19.16 | 20.32 | -- | 106.31 | -- |
| ModivCare Inc | 2.79bn | -183.04m | 230.41m | 21.20k | -- | -- | -- | 0.0827 | -12.87 | -12.87 | 196.11 | -1.19 | 1.63 | -- | 8.07 | 131,491.50 | -10.35 | -1.36 | -15.25 | -1.83 | 15.52 | 17.58 | -6.34 | -0.9619 | -- | 0.2753 | 1.01 | -- | 9.85 | 14.71 | -542.83 | -- | 19.27 | -- |
| Accolade Inc | 441.03m | -80.10m | 294.77m | 2.40k | -- | 0.6953 | -- | 0.6684 | -1.03 | -1.03 | 5.69 | 5.26 | 0.5477 | -- | 17.46 | 183,761.70 | -9.95 | -24.80 | -11.44 | -29.04 | 48.24 | 45.56 | -18.16 | -56.43 | -- | -- | 0.3308 | -- | 14.09 | 34.30 | 78.29 | -- | 31.97 | -- |
| Viemed Healthcare Inc | 214.30m | 10.43m | 370.29m | 996.00 | 37.01 | 2.96 | 10.44 | 1.73 | 0.257 | 0.257 | 5.28 | 3.21 | 1.34 | 18.96 | 9.53 | 215,161.60 | 6.56 | 12.28 | 8.40 | 15.52 | 60.28 | 62.57 | 4.88 | 10.09 | 1.19 | 9.02 | 0.0489 | 0.00 | 31.82 | 23.21 | 64.63 | 1.50 | 33.67 | -- |
| Enhabit Inc | 1.04bn | -116.60m | 402.77m | 10.80k | -- | 0.7115 | -- | 0.3883 | -2.32 | -2.32 | 20.65 | 11.26 | 0.7529 | -- | 6.51 | 96,037.04 | -8.28 | -- | -9.49 | -- | 48.79 | -- | -11.00 | -- | -- | 0.6608 | 0.468 | -- | -2.32 | -- | -99.26 | -- | -- | -- |
| DocGo Inc | 694.97m | 30.83m | 411.32m | 2.92k | 14.16 | 1.26 | 8.91 | 0.5919 | 0.284 | 0.284 | 6.41 | 3.19 | 1.52 | -- | 3.15 | 238,411.10 | 6.35 | -- | 8.97 | -- | 34.50 | -- | 4.17 | -- | -- | 61.05 | 0.1194 | -- | 41.72 | -- | -80.17 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Brown Advisory LLCas of 30 Jun 2024 | 5.45m | 6.81% |
| ARK Investment Management LLCas of 30 Sep 2024 | 5.38m | 6.73% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 5.28m | 6.59% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 4.16m | 5.20% |
| Millennium Management LLCas of 03 Oct 2024 | 4.09m | 5.11% |
| Rock Springs Capital Management LPas of 30 Jun 2024 | 2.29m | 2.86% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 1.98m | 2.48% |
| Nikko Asset Management Co., Ltd.as of 30 Sep 2024 | 1.89m | 2.36% |
| Nikko Asset Management Americas, Inc.as of 30 Sep 2024 | 1.89m | 2.36% |
| Geode Capital Management LLCas of 30 Jun 2024 | 1.70m | 2.12% |
